The data from the present study are in agreement with the above studies, since they show NR4A1 cytoplasmic expression in primary tumours that is reduced in higher grade and metastatic tumours (Figure 1c and Table 2). The gene discussed is NR4A1; the disease is metastatic neoplasm.